Ochoa Syndrome: A Comprehensive Exploration

Main Article Content

Gabriela Cruz Islas
Vanessa Iliana Palacios Raya
Ernesto Nápoles Hernández
Diego Martínez Juárez
Francisco Mayo Nava
Carlos Emilio Hernández Valdivia
Dulce María Sanabria Quinteros
Laura Aurora de la Mora Marrufo
Raúl Alonso Delgado Enríquez

Abstract

Objective: Ochoa Syndrome, also recognized as Urofacial Syndrome, presents an intricate confluence of urological anomalies and distinctive facial expressions during micturition. This article endeavors to meticulously dissect the genetic underpinnings and clinical intricacies that define this rare genetic disorder, providing a comprehensive overview for clinicians, geneticists, and researchers.


Methods: A thorough review of existing literature, genetic studies, and clinical case reports was conducted to synthesize the current understanding of Ochoa Syndrome. Molecular pathways implicated in the pathogenesis of Ochoa Syndrome, with a focus on the HPSE2 gene, were elucidated, providing a foundation for the exploration of potential therapeutic interventions.


Results: Ochoa Syndrome emerges as a consequence of mutations in the HPSE2 gene, unraveling a cascade of molecular events intricately linked to neurogenic bladder dysfunction and unique facial grimacing during voiding. The clinical spectrum encompasses a range of urological challenges, necessitating a nuanced approach to patient management and care.


Conclusion: This article illuminates the complexities of Ochoa Syndrome, offering a roadmap for clinicians and researchers to navigate the intricate genetic landscape. By elucidating the molecular labyrinth that underlies this syndrome, we aim to not only enhance diagnostic precision but also pave the way for targeted therapeutic interventions, thereby advancing our collective understanding and management of this rare genetic enigma. Through this exploration, we endeavor to foster a deeper appreciation for the intricacies of Ochoa Syndrome and underscore the imperative for continued research in the pursuit of optimal patient outcomes.

Article Details

How to Cite
Gabriela Cruz Islas, Vanessa Iliana Palacios Raya, Ernesto Nápoles Hernández, Diego Martínez Juárez, Francisco Mayo Nava, Carlos Emilio Hernández Valdivia, Dulce María Sanabria Quinteros, Laura Aurora de la Mora Marrufo, & Raúl Alonso Delgado Enríquez. (2023). Ochoa Syndrome: A Comprehensive Exploration. International Journal of Medical Science and Clinical Research Studies, 3(12), 3176–3180. https://doi.org/10.47191/ijmscrs/v3-i12-46
Section
Articles

References

I. Newman WG, Woolf AS. Urofacial syndrome. 2013. In: Seattle: University of Washington. Seattle. 1993-2023; 2018. GeneReviews®. Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors.

II. Ochoa B. Can a congenital dysfunctional bladder be diagnosed from a smile? The Ochoa syndrome updated. Pediatr Nephrol. 2004; 19: 6-12.

III. Skálová S, Rejtar I, Novák I, Jüttnerová V. The urofacial (Ochoa) syndrome--first case in the central European population. Prague Med Rep. 2006; 107: 125-9.

IV. Pang J, Zhang S, Yang P, Hawkins-Lee B, Zhong J, et al. Loss-offunction mutations in HPSE2 cause the autosomal recessive urofacial syndrome. Am J Hum Genet. 2010; 86: 957-62.

V. Mahmood S, Beetz C, Tahir MM, Imran M, Mumtaz R, et al. First HPSE2 missense mutation in urofacial syndrome. Clin Genet. 2012; 81: 88-92.

VI. Sutay NR, Kulkarni R, Arya MK. Ochoa or Urofacial syndrome. Indian Pediatr. 2010; 47: 445-6.

VII. Osorio S, Rivillas ND, Martinez JA. Urofacial (ochoa) syndrome: A literature review. J Pediatr Urol. 2021; 17: 246-54.

VIII. Schmidt W, Schroeder TM, Buchinger G, Kubli F. Genetics, pathoanatomy and prenatal diagnosis of Potter I syndrome and other urogenital tract diseases. Clin Genet. 1982; 22: 105-27.

IX. Ochoa B. The urofacial (Ochoa) syndrome revisited. J Urol. 1992; 148: 580-3.

X. Velez-Tejada P, Niño-Serna L, Serna-Higuita LM, Serrano Gayubo AK, VelezEcheverri C, et al. Evolución de los pacientes pediátricos con diagnóstico de hidronefrosis que consulton al Hospital Universitario San Vicente Fundacion, medellÿn, Colombia, entre 1960 y 2010. Iatreia. 2019; 27: 147.e54.

XI. Mermerkaya M, Suer E, Oztürk E, Glpÿnar O, Goké M, et al. Lagoftalmo noturno em crianças com síndrome urofacial (Ochoa): um novo sinal. Eur J Pediatr. 2013; 173: 661.e5.

XII. Rondon AV, Leslie B, Netto JM, Freitas RG, Ortiz V, et al. Síndrome urofacial de Ochoa: reconheça o sorriso peculiar e evite complicações urológicas e renais graves. Einstein (Sao Paulo). 2015; 13: 279-82.

XIII. Stuart HM, Roberts NA, Burgu B, Daly SB, Urquhart JE, et al. LRIG2 mutations cause urofacial syndrome. Am J Hum Genet. 2013; 92: 259-64.

Most read articles by the same author(s)